Author

Jiaqi Wu

Arizona State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Immunology· 2 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:E. coli· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Bo Zeng· 1 shared Brady Dennison· 1 shared Bryan Garcia· 1 shared Cassandra M. BarrettiD· 1 shared Ce WangiD· 1 shared Dasol Wi· 1 shared Dat NgoiD· 1 shared Eric R. HaasiD· 1 shared

Activity by Year

2018-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bo Zeng

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Myeloid DC-SIGN drives tumor immune evasion and resistance to PD-1 blockade through ICAM-2-ERM-mediated T-cell mechanosuppression

Ting Pan, T Z Wang, Jiaqi Wu, Heping Wang, Bo Zeng, Yangyang Li, Ming Yi, Ruirui He, Lingyun Feng, Zhihui Cui, Guoling Huang, Panyin Shu, Xi Li, Yuan Wang, Yanyun Du, , Ce Wang

This study identifies DC-SIGN as a mechanosuppressive checkpoint that drives tumor immune evasion and resistance to PD-1 blockade by suppressing T-cell function through ICAM-2-ERM signaling.

bioRxiv · Jun 16, 2026 · PreprintImmunology

Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy

Lior Goldberg, Eric R. Haas, Jiaqi Wu, Bryan Garcia, Ryan Z. Urak, Vibhuti Vyas, Ruby Espinosa, Tamara Munoz, Shirley Bierkatz, Khyatiben V. Pathak, Nathaniel P. Hansen, Patrick Pirrotte, Jyotsana Singhal, James Lester Figarola, Ricardo Zerda Noriega, , Xiuli Wang

This study identifies immunometabolic factors in CD19 CAR T cells that predict long-term response in B-ALL patients and suggests mTOR inhibition as a strategy to enhance anti-tumor activity.

Nature Communications · Feb 20, 2026Peer-reviewedImmunology

Characterization of Diverse Homoserine Lactone Synthases in Escherichia coli

René Daer, Cassandra M. Barrett, Ernesto Luna Melendez, Jiaqi Wu, Stefan J. Tekel, Jimmy M. Xu, Brady Dennison, Ryan Yue Muller, Karmella Ann Haynes

This study characterizes ten homoserine lactone synthases in E. coli, showing their compatibility with the Lux pathway and highlighting disposal risks of HSLs.

PLoS ONE · Aug 23, 2018Peer-reviewedSynthetic Biology